MC1315A1 - Derives de l'imidazole et leur synthese et preparation de medicaments contenant ces substances - Google Patents
Derives de l'imidazole et leur synthese et preparation de medicaments contenant ces substancesInfo
- Publication number
- MC1315A1 MC1315A1 MC801433A MC1433A MC1315A1 MC 1315 A1 MC1315 A1 MC 1315A1 MC 801433 A MC801433 A MC 801433A MC 1433 A MC1433 A MC 1433A MC 1315 A1 MC1315 A1 MC 1315A1
- Authority
- MC
- Monaco
- Prior art keywords
- imidazole
- group
- formula
- heteroatoms
- radical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
- C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
- C07C29/14—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of a —CHO group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
- C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
- C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7906243 | 1979-02-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MC1315A1 true MC1315A1 (fr) | 1981-03-10 |
Family
ID=10503360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MC801433A MC1315A1 (fr) | 1979-02-22 | 1980-02-21 | Derives de l'imidazole et leur synthese et preparation de medicaments contenant ces substances |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US4328234A (OSRAM) |
| EP (1) | EP0015002B1 (OSRAM) |
| JP (1) | JPS55115872A (OSRAM) |
| KR (1) | KR850000380B1 (OSRAM) |
| AT (1) | AT373881B (OSRAM) |
| AU (1) | AU531899B2 (OSRAM) |
| DE (1) | DE3067505D1 (OSRAM) |
| DK (1) | DK75680A (OSRAM) |
| ES (1) | ES488803A0 (OSRAM) |
| FI (1) | FI800519A7 (OSRAM) |
| GB (1) | GB2044259B (OSRAM) |
| GR (1) | GR70277B (OSRAM) |
| HU (1) | HU188123B (OSRAM) |
| IE (1) | IE49744B1 (OSRAM) |
| IL (1) | IL59444A0 (OSRAM) |
| IT (1) | IT1128095B (OSRAM) |
| MC (1) | MC1315A1 (OSRAM) |
| NZ (1) | NZ192941A (OSRAM) |
| PT (1) | PT70856B (OSRAM) |
| ZA (1) | ZA80996B (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR70277B (OSRAM) * | 1979-02-22 | 1982-09-03 | Wellcome Found | |
| DE2944662A1 (de) * | 1979-11-06 | 1981-05-14 | Bayer Ag, 5090 Leverkusen | Cycloheptatrienylimidazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
| DE2944663A1 (de) * | 1979-11-06 | 1981-05-14 | Bayer Ag, 5090 Leverkusen | Imidazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
| JPS6036427B2 (ja) * | 1980-12-05 | 1985-08-20 | 塩野義製薬株式会社 | １−ベンジルイミダゾ−ル誘導体 |
| DE3465993D1 (en) * | 1983-08-11 | 1987-10-15 | Synthelabo | Indole derivatives, their preparation and their therapeutical application |
| DE3508905A1 (de) * | 1985-03-13 | 1986-09-18 | Hoechst Ag, 6230 Frankfurt | Neue imidazolylverbindungen und verfahren zu ihrer herstellung |
| US4783474A (en) * | 1985-07-20 | 1988-11-08 | Bayer Aktiengesellschaft | Halogenoalkyl-, alkenyl- and alkinyl-azoles |
| DE3700916A1 (de) * | 1987-01-14 | 1988-07-28 | Bayer Ag | Halogenalkyl-, alkenyl- und alkinyl-azole |
| US5272167A (en) * | 1986-12-10 | 1993-12-21 | Schering Corporation | Pharmaceutically active compounds |
| DE3827117A1 (de) * | 1988-08-10 | 1990-02-15 | Ruetgerswerke Ag | Verfahren zur herstellung von chinuclidin-3-methanol |
| IT1251431B (it) * | 1991-10-25 | 1995-05-09 | Costante Fontana | Composto ad elevate caratteristiche stabilizzanti particolarmente per perossidi inorganici utilizzati in applicazioni industriali |
| BR9610960A (pt) * | 1995-10-13 | 1999-03-02 | Neurosearch As | Derivados de 8-azabiciclo [3.2.1] oct -2- eno sua preparação e uso |
| CA2601575A1 (en) * | 2005-03-31 | 2006-10-05 | Schering Corporation | Spirocyclic thrombin receptor antagonists |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2836598A (en) * | 1958-05-27 | Tertiary-amino - substituted i | ||
| US29935A (en) * | 1860-09-04 | Joseph f | ||
| US3259637A (en) * | 1963-05-27 | 1966-07-05 | Frosst & Co Charles E | 3, 3-dimethyl-8-bromomethyl-2, 7-dioxaspiro (4.4)nonane |
| GB1164564A (en) | 1967-08-21 | 1969-09-17 | Shell Int Research | Novel Cyclobexylpentadienone Acid Derivatives, the preparation thereof and Compositions containing the same |
| USRE29935E (en) * | 1968-11-29 | 1979-03-13 | Bayer Aktiengesellschaft | N-Substituted imidazoles and their salts |
| DE2007794A1 (de) * | 1970-02-20 | 1971-09-02 | Farbenfabriken Bayer Aktiengesell schaft, 5090 Leverkusen | Fungizide Mittel |
| US3666755A (en) * | 1970-03-26 | 1972-05-30 | Merck & Co Inc | 2-imidazolylbicyclo{8 2.2.2{9 octanes |
| DE2016839C3 (de) * | 1970-04-09 | 1979-03-22 | Bayer Ag, 5090 Leverkusen | PhenyM4-phenoxyphenyi)-imidazol-1-yl-methane, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel |
| US3682951A (en) * | 1970-11-02 | 1972-08-08 | Searle & Co | 1-{8 {62 -(1-adamantyloxy)halophenethyl{9 {0 imidazoles and congeners |
| FR2129838A1 (en) * | 1971-03-16 | 1972-11-03 | Boehringer Mannheim Gmbh | Diuretic/saluretic dibenzo cycloheptene - derivs |
| US4107206A (en) * | 1974-04-08 | 1978-08-15 | Akzona Incorporated | Benzo-bicyclononene- derivatives |
| SE7600674L (sv) * | 1975-02-05 | 1976-08-06 | Rohm & Haas | Fungicider |
| US4057549A (en) * | 1975-04-16 | 1977-11-08 | G. D. Searle & Co. | Triarylpropyl-azabicyclooctanes |
| US4156694A (en) * | 1975-04-29 | 1979-05-29 | Akzona Incorporated | Benzobicyclononene derivatives |
| US4036975A (en) * | 1975-07-28 | 1977-07-19 | Xyntex (U.S.A) Inc. | 1-[2-(1-Adamantyl)-2-(R-thio)ethyl]imidazoles and 1-[2-(1-adamantyl)-2-(R-oxy)ethyl]imidazoles |
| US4031224A (en) * | 1976-04-29 | 1977-06-21 | American Hoechst Corporation | 1,3-Dihydro-heteroarylspiro (isobenzofuran)s |
| US4396771A (en) * | 1977-10-19 | 1983-08-02 | Burroughs Wellcome Co. | Imidazole derivatives and salts thereof |
| EP0003732B1 (en) * | 1978-02-01 | 1983-10-19 | The Wellcome Foundation Limited | Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof |
| GR70277B (OSRAM) * | 1979-02-22 | 1982-09-03 | Wellcome Found |
-
1980
- 1980-02-21 GR GR61259A patent/GR70277B/el unknown
- 1980-02-21 ES ES488803A patent/ES488803A0/es active Granted
- 1980-02-21 PT PT70856A patent/PT70856B/pt unknown
- 1980-02-21 FI FI800519A patent/FI800519A7/fi not_active Application Discontinuation
- 1980-02-21 DK DK75680A patent/DK75680A/da not_active Application Discontinuation
- 1980-02-21 NZ NZ192941A patent/NZ192941A/xx unknown
- 1980-02-21 US US06/123,712 patent/US4328234A/en not_active Expired - Lifetime
- 1980-02-21 GB GB800588A patent/GB2044259B/en not_active Expired
- 1980-02-21 IE IE341/80A patent/IE49744B1/en unknown
- 1980-02-21 IL IL59444A patent/IL59444A0/xx unknown
- 1980-02-21 KR KR1019800000712A patent/KR850000380B1/ko not_active Expired
- 1980-02-21 JP JP2106080A patent/JPS55115872A/ja active Pending
- 1980-02-21 ZA ZA00800996A patent/ZA80996B/xx unknown
- 1980-02-21 MC MC801433A patent/MC1315A1/fr unknown
- 1980-02-21 EP EP80100869A patent/EP0015002B1/en not_active Expired
- 1980-02-21 DE DE8080100869T patent/DE3067505D1/de not_active Expired
- 1980-02-21 HU HU80410A patent/HU188123B/hu unknown
- 1980-02-21 AU AU55765/80A patent/AU531899B2/en not_active Ceased
- 1980-02-21 AT AT0097580A patent/AT373881B/de not_active IP Right Cessation
- 1980-02-21 IT IT47968/80A patent/IT1128095B/it active
-
1982
- 1982-09-29 US US06/427,856 patent/US4525475A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES8103055A1 (es) | 1981-02-16 |
| AT373881B (de) | 1984-02-27 |
| HU188123B (en) | 1986-03-28 |
| PT70856B (en) | 1981-06-11 |
| US4525475A (en) | 1985-06-25 |
| GR70277B (OSRAM) | 1982-09-03 |
| IL59444A0 (en) | 1980-05-30 |
| GB2044259A (en) | 1980-10-15 |
| ATA97580A (de) | 1983-07-15 |
| PT70856A (en) | 1980-03-01 |
| US4328234A (en) | 1982-05-04 |
| ES488803A0 (es) | 1981-02-16 |
| AU531899B2 (en) | 1983-09-08 |
| EP0015002A1 (en) | 1980-09-03 |
| EP0015002B1 (en) | 1984-04-18 |
| JPS55115872A (en) | 1980-09-06 |
| DE3067505D1 (en) | 1984-05-24 |
| FI800519A7 (fi) | 1981-01-01 |
| IE800341L (en) | 1980-08-22 |
| NZ192941A (en) | 1984-10-19 |
| IT1128095B (it) | 1986-05-28 |
| IT8047968A0 (it) | 1980-02-21 |
| GB2044259B (en) | 1983-08-03 |
| IE49744B1 (en) | 1985-12-11 |
| KR830001904A (ko) | 1983-05-19 |
| KR850000380B1 (ko) | 1985-03-23 |
| AU5576580A (en) | 1980-08-28 |
| DK75680A (da) | 1980-08-23 |
| ZA80996B (en) | 1981-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112424174B (zh) | 可用于治疗疾病的杂环化合物 | |
| MC1241A1 (fr) | Derives de l'imidazole et leur preparation et preparation de medicaments contenant ces substances | |
| JP6926189B2 (ja) | エストロゲン受容体調節薬 | |
| EP2507238B1 (fr) | Derives de diphenyl-pyrazolopyridines, leur preparation et leur application en tant que modulateurs du récepteur nucléaire not | |
| JP7198820B2 (ja) | 置換アゼチジンジヒドロチエノピリミジンおよびホスホジエステラーゼ阻害剤としてのそれらの使用 | |
| JP6689856B2 (ja) | ６，７−ジヒドロピラゾロ［１，５−ａ］ピラジン−４（５Ｈ）−オン化合物およびＭＧＬＵＲ２受容体の負のアロステリック調節因子としてのそれらの使用 | |
| US11981681B2 (en) | Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors | |
| JP6786566B2 (ja) | ヘテロアリール化合物及びその使用方法 | |
| MC1315A1 (fr) | Derives de l'imidazole et leur synthese et preparation de medicaments contenant ces substances | |
| EP3535268B1 (en) | [1,2,4]triazolo[1,5-a]pyrimidine compounds as pde2 inhibitors | |
| JP2021535154A (ja) | バニン阻害剤としてのヘテロ芳香族化合物 | |
| CN119039290A (zh) | P2x3调节剂 | |
| JP6174695B2 (ja) | ホスホジエステラーゼ１０酵素の阻害剤 | |
| NL2000336C2 (nl) | Spirocyclische derivaten. | |
| KR20140105598A (ko) | [1,2,4]트리아졸로피리딘 및 포스포디에스테라제 억제제로서의 이의 용도 | |
| MC1221A1 (fr) | Derives de l'imidazole et leurs sels,leur synthese et leurs produits intermediaires,et preparation de compositions pharmaceutiques contenant ces substances | |
| FR2492378A1 (fr) | Derives de type 6h-dibenzo(b,d) pyranne 6-substitues utiles notamment comme medicaments antiulcereux, immunomodulateurs et antiviraux et procedes de leur preparation | |
| FR2610932A1 (fr) | Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament | |
| EP0238883B1 (en) | Oxabicycloheptane derivatives, pharmaceutical composition and use | |
| EP1828125B1 (fr) | Derives d'arylpiperazine et leur utilisation comme ligands selectifs du recepteur d3 de la dopamine | |
| MC1211A1 (fr) | Derives de l'imidazole et leur preparation | |
| HK40039957A (en) | Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors | |
| HK40039957B (en) | Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors | |
| JPWO2000059913A1 (ja) | 新規チアゾロベンゾイミダゾール誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| YP | Annual fee paid |